Knowledge and Perspective of Healthcare Professionals About Female Genital Mutation (FMG-HCPROF)

February 4, 2022 updated by: Simone Ferrero, Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia

Knowledge and Perspective of Healthcare Professionals Related to Female Genital Mutation: a Regional Survey

Each year over three million girls are at risk of being subjected to female genital mutilation (FGM) in several African countries. This regional survey aims to evaluate knowledge and perspective of healthcare professionals related to FGM.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The survey iscomposed of 4 different sections: the first section included questions about demographic data of participants; the second part evaluated responders' knowledge about FGM; the third section focused on participants' working experience with patients affected by FGM and personal attitude related to this topic.

Study Type

Observational

Enrollment (Actual)

450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Italy
      • Genova, Italy, 16132
        • IRCCS Ospedale Policlinico San Martino

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

healthcare professionals working in Genoa

Description

Inclusion Criteria:

  • medical specialists
  • general medical practicians
  • medical residents
  • midwives
  • professional nurses
  • medical students
  • residence in Liguria (Italy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthcare professionals
Healthcare professionals (medical specialists and general practitioners, medical residents, midwives, professional nurses, medical students).
Behavioral: Survey
The survey is composed of 4 different sections: the first section included questions about demographic data of participants; the second part evaluated responders' knowledge about FGM; the third section focused on participants' working experience with patients affected by FGM and personal attitude related to this topic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean score related to knowledge about FGM
Time Frame: Baseline
10-point score (0:minimal knowledge; 10: extensive knowledge) related to the knowledge of responders about FGM
Baseline
Proportion of responders with active role in contrasting the procedures
Time Frame: Baseline
Evalution of the personale attitude of responders to the topic (active role in contrasting the procedures)
Baseline
Proportion of responders feeling confortable in treating patients affected
Time Frame: Baseline
Evalution of the personale attitude of responders to the topic (responders feeling confortable in treating patients affected)
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Piazza della Vittoria 14 Studio Medico - Ginecologia e Ostetricia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Actual)

June 30, 2021

Study Completion (Actual)

July 31, 2021

Study Registration Dates

First Submitted

June 19, 2021

First Submitted That Met QC Criteria

June 19, 2021

First Posted (Actual)

June 23, 2021

Study Record Updates

Last Update Posted (Actual)

February 7, 2022

Last Update Submitted That Met QC Criteria

February 4, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • FMG-HEALTHCAREPROF-SURVEY

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Female Genital Mutilation Type I Status

Clinical Trials on Survey

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe